COVID trial using antidepressant cut short due to apparent effectiveness – Ars Technica

1. COVID trial using antidepressant cut short due to apparent effectiveness  Ars Technica
2. Antidepressant COVID-19 treatment shows promise in early study: Fluvoxamine  11Alive
3. Cheap antidepressant shows promise treating early COVID-19  Yahoo News
4. Cheap, generic anti-depressant may reduce severe Covid-19 disease, study finds  CNN
5. Antidepressant May Cut COVID-Related Hospitalization, Mortality  Medscape

Source: Weather